<DOC>
	<DOC>NCT02526550</DOC>
	<brief_summary>This study was undertaken to assess the immunogenicity and safety of a booster dose of a live attenuated chimeric Japanese Encephalitis vaccine (JE-CV) after primary vaccination with SA14-14-2 in Thai children aged 1 to &lt;5 years. In addition, to assess the impact of the duration interval after primary vaccination on subsequent booster response.</brief_summary>
	<brief_title>Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAX</brief_title>
	<detailed_description>The subject will receive one booster dose of IMOJEV with hepatitis A vaccine (inactivated vaccine of GlaxoSmithKline) as concomitant vaccine. Blood samples will be collected to assess for Japanese Encephalitis Neutralizing Antibody at baseline (pre-vaccination) and 4 week post -vaccination.</detailed_description>
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis, Japanese</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Children aged 1 to &lt;5 years on the day of inclusion History of received 1 dose of CD.JEVAX at 915 months prior to enrollment In good general health at the time of inclusion Provision of informed consent by the parent(s) or legal guardian(s) Receipt of blood or blood products in the past 3 months Acute febrile illness on the day of vaccination (Body Temperature ≥ 38 ◦C) Previous receipt of 2 doses of any vaccine against JE virus Known hypersensitivity to any of the vaccine components Any confirmed or suspected immunosuppressive or immunodeficient condition, based on medical history and physical examination Planned receipt of any live attenuated vaccine within 4 weeks following the trial vaccination</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Live attenuated Japanese Encephalitis vaccine</keyword>
	<keyword>IMOJEV</keyword>
	<keyword>CD.JEVAX</keyword>
	<keyword>Booster</keyword>
	<keyword>Thai children</keyword>
	<keyword>Immunogenicity</keyword>
	<keyword>Safety</keyword>
	<keyword>Interchangeability</keyword>
	<keyword>Hepatitis A vaccine</keyword>
	<keyword>Vaccination or Other Immunization Procedure</keyword>
</DOC>